v3.25.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance at the beginning (in shares) at Dec. 31, 2023   151,310,080      
Balance at the beginning at Dec. 31, 2023 $ 144,140 $ 15 $ 444,825 $ (53) $ (300,647)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   2,557,792      
Issuance of common stock upon exercise of stock options 1,810 $ 1 1,809    
Issuance of common stock upon vesting of restricted stock units (in shares)   5,734,197      
Stock-based compensation cost 25,697   25,697    
Cumulative translation adjustment 21     21  
Net loss (54,017)       (54,017)
Balance at the end (in shares) at Dec. 31, 2024   159,602,069      
Balance at the end at Dec. 31, 2024 $ 117,651 $ 16 472,331 (32) (354,664)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 9,395,646 9,357,144      
Issuance of common stock upon exercise of stock options $ 9,085 $ 2 9,083    
Issuance of common stock upon vesting of restricted stock units (in shares)   5,593,282      
Issuance of common stock upon exercise of warrants (in shares)   117,423      
Issuance of common stock upon exercise of warrants $ 49   49    
Issuance of common stock upon transfer of contingently issuable common stock liability (in shares) 729,570 729,570      
Issuance of common stock upon transfer of contingently issuable common stock $ 3,671   3,671    
Stock-based compensation cost 22,213   22,213    
Cumulative translation adjustment (109)     (109)  
Net loss (33,138)       (33,138)
Balance at the end (in shares) at Dec. 31, 2025   175,399,488      
Balance at the end at Dec. 31, 2025 $ 119,422 $ 18 $ 507,347 $ (141) $ (387,802)